Fiona Stanley Hospital

Az itteni vizsgálatok

Miről szól a helyszín 127 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Colitis ulcerosa11 vizsgálat
• Prosztatarák11 vizsgálat
• Stroke (szélütés)11 vizsgálat
• Mielóma multiplex8 vizsgálat
• Aortic stenosis7 vizsgálat
• Crohn-betegség7 vizsgálat
• Gyermekkori daganatok5 vizsgálat
• Koszorúér-betegség5 vizsgálat
• Magas vérnyomás5 vizsgálat
• Melanóma5 vizsgálat
• Tüdőrák5 vizsgálat
• Akut mieloid leukémia (AML)4 vizsgálat
• és még 36

Fázis

• 3. fázis78 vizsgálat
• 2. fázis22 vizsgálat
• 2/3. fázis8 vizsgálat
• 1. fázis2 vizsgálat
• 1/2. fázis2 vizsgálat
• 4. fázis1 vizsgálat

Állapot

• Fut, nem toboroz46 vizsgálat
• Toboroz37 vizsgálat
• Lezárult29 vizsgálat
• Még nem toboroz6 vizsgálat
• Leállították5 vizsgálat
• Visszavonták2 vizsgálat
• Meghívásos bevonás1 vizsgálat
• Felfüggesztve1 vizsgálat

Fő szponzor

• Janssen Research & Development, LLC19 vizsgálat
• Amgen6 vizsgálat
• Boehringer Ingelheim6 vizsgálat
• Abbott Medical Devices5 vizsgálat
• Eli Lilly and Company5 vizsgálat
• és még 65

Futó vizsgálatok

• Még nem toboroz

  Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

  NCT07634289· 2. fázis· Olivia Newton-John Cancer Research Institute· Forrás

• Még nem toboroz

  Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR

  NCT07696182· Abbott Medical Devices· Forrás

  Contact: Nadia Bouhdi

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Boehringer Ingelheim· Forrás

  Contact: Boehringer Ingelheim

• Toboroz

  Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07562152· 3. fázis· Immuneering Corporation· Forrás

  Contact: Study Team

• Toboroz

  Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

  NCT07486817· 2. fázis· Boehringer Ingelheim· Forrás

  Contact: Boehringer Ingelheim

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  NCT07577843· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  NCT07409181· 2. fázis· Boehringer Ingelheim· Forrás

  Contact: Boehringer Ingelheim

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  NCT07284849· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07258511· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

  NCT06980480· 3. fázis· Takeda· Forrás

  Contact: Paul Cannell (principal investigator)

• Toboroz

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· 3. fázis· Eli Lilly and Company· Forrás

  Contact: Oyekoya Ayonrinde (principal investigator)

• Toboroz

  A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

  NCT07149857· 2. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  NCT07196722· 2/3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· 3. fázis· Novo Nordisk A/S· Forrás

  Contact: Novo Nordisk

• Toboroz

  The Multicentre Selective Lymphadenectomy Trial - 3

  NCT07049276· Melanoma Institute Australia· Forrás

  Contact: Lydia Warburton

• Fut, nem toboroz

  A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07196748· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  NCT06979336· 2. fázis· Genentech, Inc.· Forrás

• Toboroz

  Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  NCT07007312· 3. fázis· Kura Oncology, Inc.· Forrás

• Toboroz

  A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  NCT07164443· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06948318· 3. fázis· Takeda· Forrás

  Contact: Dominic Pepperell (principal investigator)

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· 3. fázis· Amgen· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás

  Contact: Boehringer Ingelheim

• Toboroz

  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  NCT06943755· 2/3. fázis· Exelixis· Forrás

  Contact: Exelixis Clinical Trials

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· 3. fázis· Amgen· Forrás

• Toboroz

  ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  NCT06902558· 2. fázis· Calico Life Sciences LLC· Forrás

  Contact: Ashley Irish, MD

• Toboroz

  Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

  NCT06850727· 2. fázis· Odyssey Therapeutics, Inc.· Forrás

  Contact: Study Coordinator

• Toboroz

  A Study of Transcatheter Aortic Valve Replacement Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm

  NCT06991517· World Health Research Inc.· Forrás

  Contact: Sarah Tawadros, MD

• Toboroz

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  NCT06563895· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819878· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06722235· 3. fázis· Takeda· Forrás

  Contact: Dominic Pepperell (principal investigator)

• Fut, nem toboroz

  Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

  NCT06691984· 3. fázis· Amgen· Forrás

• Fut, nem toboroz

  Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

  NCT06578247· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

  NCT06561386· 3. fázis· Bristol-Myers Squibb· Forrás

  Contact: Lydia Warburton, Site 0053

• Fut, nem toboroz

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06589986· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06564142· 3. fázis· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Forrás

• Toboroz

  Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

  NCT06226805· 2. fázis· Basking Biosciences, Inc.· Forrás

  Contact: Study Coordinator

• Toboroz

  Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

  NCT06277037· Arbutus Biopharma Corporation· Forrás

  Contact: Sam Galhenage

• Toboroz

  MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma

  NCT06414148· 2. fázis· Peter MacCallum Cancer Centre, Australia· Forrás

• Fut, nem toboroz

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· 2/3. fázis· CSL Behring· Forrás

  Contact: Trial Registration Coordinator

• Fut, nem toboroz

  Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients

  NCT06408935· 3. fázis· Janssen-Cilag Ltd.· Forrás

• Fut, nem toboroz

  Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

  NCT06117774· 3. fázis· Amgen· Forrás

• Toboroz

  Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  NCT06056830· 3. fázis· Clarity Pharmaceuticals Ltd· Forrás

  Contact: Dickon Hayne, MD

• Fut, nem toboroz

  Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06029972· 2. fázis· Gilead Sciences· Forrás

• Fut, nem toboroz

  A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

  NCT05257083· 3. fázis· Stichting European Myeloma Network· Forrás

• Toboroz

  Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  NCT05727904· 3. fázis· Iovance Biotherapeutics, Inc.· Forrás

  Contact: Iovance Biotherapeutics Study Team

• Fut, nem toboroz

  A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

  NCT05572515· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System

  NCT05501873· Boston Scientific Corporation· Forrás

Showing 50 of 90.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Colitis ulcerosa3 toboroz
• Crohn-betegség3 toboroz
• Gyermekkori daganatok3 toboroz
• Mielóma multiplex3 toboroz
• Akut mieloid leukémia (AML)2 toboroz
• Amiloidózis2 toboroz
• Aortic stenosis2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Hasnyálmirigyrák2 toboroz
• Immune thrombocytopenia (ITP)2 toboroz
• Koszorúér-betegség2 toboroz
• Melanóma2 toboroz
• Neuroendokrin daganatok2 toboroz
• Prosztatarák2 toboroz
• Stroke (szélütés)2 toboroz
• Szívelégtelenség2 toboroz
• Tüdőrák2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Elhízás1 toboroz
• Hemofília1 toboroz
• Hepatitis B (krónikus)1 toboroz
• Krónikus vesebetegség1 toboroz
• Lupus (SLE)1 toboroz
• Magas vérnyomás1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Peripheral artery disease1 toboroz
• Policisztás vesebetegség1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vastagbélrák1 toboroz
• Zsírmáj (MASLD/MASH)1 toboroz

Lezárt vizsgálatok

• Leállították

  A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

  NCT07076550· 1. fázis· Alpha-9 Oncology USA Inc.· Forrás

• Visszavonták

  Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

  NCT06598631· 2. fázis· Eli Lilly and Company· Forrás

• Leállították

  A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

  NCT06256484· 1. fázis· Atara Biotherapeutics· Forrás

• Toboroz

  Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

  NCT05950945· 3. fázis· Daiichi Sankyo· Forrás

• Leállították

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· 2. fázis· Pliant Therapeutics, Inc.· Forrás

• Lezárult

  IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)

  NCT05989711· 2. fázis· Altimmune, Inc.· Forrás

• Lezárult

  A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

  NCT05953480· 2. fázis· Shionogi· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Lezárult

  A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC

  NCT05611671· 2. fázis· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· 2/3. fázis· argenx· Forrás

• Lezárult

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

  NCT05014672· 2. fázis· Calliditas Therapeutics Suisse SA· Forrás

• Lezárult

  Cochlear Implant With Dexamethasone Eluting Electrode Array

  NCT04750642· Cochlear· Forrás

• Lezárult

  Allergic Disease Onset Prevention Study

  NCT05003804· 1/2. fázis· Siolta Therapeutics, Inc.· Forrás

• Leállították

  Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

  NCT04778397· 3. fázis· Gilead Sciences· Forrás

• Lezárult

  Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

  NCT03734640· Craig Anderson· Forrás

• Lezárult

  Preventing Adverse Cardiac Events in COPD

  NCT03917914· 3. fázis· The George Institute· Forrás

• Leállították

  Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

  NCT04365868· 2/3. fázis· Galectin Therapeutics Inc.· Forrás

• Lezárult

  A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

  NCT04083235· 3. fázis· Ipsen· Forrás

• Lezárult

  A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

  NCT04083976· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Optimize PRO Study

  NCT04091048· Medtronic Cardiovascular· Forrás

• Lezárult

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· 3. fázis· Amgen· Forrás

• Lezárult

  A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

  NCT03626688· 3. fázis· United Therapeutics· Forrás

• Lezárult

  A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

  NCT03587116· 3. fázis· Pfizer· Forrás

• Lezárult

  Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

  NCT03260894· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT03277105· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial

  NCT02699645· 3. fázis· The George Institute· Forrás

• Lezárult

  Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

  NCT03173560· 2. fázis· Eisai Inc.· Forrás

• Lezárult

  A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

  NCT02908672· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· 3. fázis· Takeda· Forrás

• Lezárult

  A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

  NCT02684006· 3. fázis· Pfizer· Forrás

• Lezárult

  Avelumab in First-line NSCLC (JAVELIN Lung 100)

  NCT02576574· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

  NCT02398656· 3. fázis· University of Calgary· Forrás

• Lezárult

  Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

  NCT02273375· 3. fázis· Canadian Cancer Trials Group· Forrás

• Lezárult

  A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

  NCT01740427· 3. fázis· Pfizer· Forrás